Eleven Biotherapeutics (EBIO) Reports Fiscal First Quarter 2014 Financial Results
5/15/2014 9:43:33 AM
Eleven Biotherapeutics, Inc. (Nasdaq: EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today reported financial results and operational highlights for the quarter ended March 31, 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by